Cargando…
Advances in Glucocorticoid-Induced Osteoporosis
Glucocorticoid-induced osteoporosis (GIOP) is one of the most important side effects of glucocorticoid use, as it leads to an increased risk of fractures. Recently, many published studies have focused on the cellular and molecular mechanisms of bone metabolism, the pathophysiology of GIOP, and the i...
Autores principales: | den Uyl, Debby, Bultink, Irene E. M., Lems, Willem F. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Current Science Inc.
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3092927/ https://www.ncbi.nlm.nih.gov/pubmed/21365209 http://dx.doi.org/10.1007/s11926-011-0173-y |
Ejemplares similares
-
Bisphosphonates and glucocorticoid-induced osteoporosis: cons
por: Lems, Willem F., et al.
Publicado: (2015) -
Exercise-induced changes in interleukin-10 in patients with knee osteoarthritis: new perspectives?
por: Lems, Willem F, et al.
Publicado: (2010) -
(Sub)clinical cardiovascular disease is associated with increased bone loss and fracture risk; a systematic review of the association between cardiovascular disease and osteoporosis
por: den Uyl, Debby, et al.
Publicado: (2011) -
Systemic lupus erythematosus and fractures
por: Bultink, Irene E M, et al.
Publicado: (2015) -
Glucocorticoids: bad or safe for the bones?
por: Lems, Willem F
Publicado: (2015)